Veradermics, Inc. (MANE)

100.07 -0.31 (-0.31%) USD  |  NYSE  |  May 19, 16:00
99.92 -0.15 (-0.15%) After-Hours: 20:00
More

Veradermics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for MANE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Organon & Co. Upgrade
Merck & Co., Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Terns Pharmaceuticals, Inc. (DELISTED) Upgrade
Corcept Therapeutics, Inc. Upgrade